Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liyan Xue

Showing results (161-170 of 174) with videos related to

Pageof 18
Sort By:
Signal Transduction and Targeted Therapy|September 5, 2020
An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinomaChaoqi Zhang, Guochao Zhang, Nan Sun, et al.
Gastroenterology|October 30, 2024
A High-Resolution Microendoscope Improves Esophageal Cancer Screening and Surveillance: Implications for Underserved Global Settings Based on an International Randomized Controlled TrialMimi C Tan, Zhengqi Li, Kalpesh K Patel, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 22, 2022
Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC)Yan Dong, Liyan Xue, Yan Zhang, et al.
The American Journal of Pathology|April 17, 2010
The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancersElodie E Noel, Marc Yeste-Velasco, Xueying Mao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 12, 2025
A multidimensional deep ensemble learning model predicts pathological response and outcomes in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy from pretreatment CT imaging: A multicenter studyYunsong Liu, Yang Su, Jun Peng, et al.
Cancer Letters|June 12, 2025
Identification of an Individualized Immune-Related miRNA Pair Signature for Survival Prediction of Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell CancerPeng Wu, Dexin Shang, Li Liu, et al.
Clinical and Translational Medicine|September 8, 2020
A three-lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapyChaoqi Zhang, Zhihui Zhang, Guochao Zhang, et al.
The American Journal of Gastroenterology|March 27, 2023
Radiotherapy Improves Survival of Patients With Lymphovascular Invasion in pT1b Esophageal Squamous Cell Cancer After Endoscopic Submucosal DissectionXu Yang, Lina Zhao, Anhui Shi, et al.
BMC Medicine|March 7, 2023
Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial : A randomized clinical trial of neoadjuvant therapy for ESCCYong Li, Aiping Zhou, Shuoyan Liu, et al.
Gastroenterology|May 19, 2015
Low-Cost High-Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia: An International TrialMarion-Anna Protano, Hong Xu, Guiqi Wang, et al.
Pageof 18

Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
Signal Transduction and Targeted Therapy|September 5, 2020
An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinomaChaoqi Zhang, Guochao Zhang, Nan Sun, et al.
Gastroenterology|October 30, 2024
A High-Resolution Microendoscope Improves Esophageal Cancer Screening and Surveillance: Implications for Underserved Global Settings Based on an International Randomized Controlled TrialMimi C Tan, Zhengqi Li, Kalpesh K Patel, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 22, 2022
Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC)Yan Dong, Liyan Xue, Yan Zhang, et al.
The American Journal of Pathology|April 17, 2010
The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancersElodie E Noel, Marc Yeste-Velasco, Xueying Mao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 12, 2025
A multidimensional deep ensemble learning model predicts pathological response and outcomes in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy from pretreatment CT imaging: A multicenter studyYunsong Liu, Yang Su, Jun Peng, et al.
Cancer Letters|June 12, 2025
Identification of an Individualized Immune-Related miRNA Pair Signature for Survival Prediction of Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell CancerPeng Wu, Dexin Shang, Li Liu, et al.
Clinical and Translational Medicine|September 8, 2020
A three-lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapyChaoqi Zhang, Zhihui Zhang, Guochao Zhang, et al.
The American Journal of Gastroenterology|March 27, 2023
Radiotherapy Improves Survival of Patients With Lymphovascular Invasion in pT1b Esophageal Squamous Cell Cancer After Endoscopic Submucosal DissectionXu Yang, Lina Zhao, Anhui Shi, et al.
BMC Medicine|March 7, 2023
Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial : A randomized clinical trial of neoadjuvant therapy for ESCCYong Li, Aiping Zhou, Shuoyan Liu, et al.
Gastroenterology|May 19, 2015
Low-Cost High-Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia: An International TrialMarion-Anna Protano, Hong Xu, Guiqi Wang, et al.
Pageof 18